MedTrace Logo

Observational Study of the Argus® II Retinal Prosthesis System

NCT01999049 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2015-04-24

No results posted yet for this study

Summary

The Argus II Retinal Implant is a revolutionary new device, which offers vision to patients who are blind from retinal degeneration - retinitis pigmentosa. These patients have no alternatives. Patients typically can achieve ambulatory vision.

Conditions

Sponsors & Collaborators

  • Foundation Fighting Blindness

    collaborator OTHER

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Robert Devenyi, MD · University Health Network- Toronto Western Hospital

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-01-31
Completion
2017-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01999049 on ClinicalTrials.gov